MEDiSTRAVA, an Inizio Company’s cover photo
MEDiSTRAVA, an Inizio Company

MEDiSTRAVA, an Inizio Company

Pharmaceutical Manufacturing

London, England 2,864 followers

About us

TIME FOR TRANSFORMATION The real world is now a multi-dimensional universe of decision makers, evidence needs and healthcare systems requiring a connected, systematic and dynamic approach to medical and evidence planning, data dissemination, stakeholder engagement and education. The opportunity extends beyond traditional medical agency services to meet the growing and diversifying needs of medical affairs and finding integrated solutions in a fragmented and underserved market. We bring more than 20 years of experience in medical affairs with deep therapeutic expertise across oncology, specialised medicine and effecting change in chronic diseases. MEDiSTRAVA is part of Inizio Medical. Inizio is a strategic partner for health and life sciences with a full suite of medical, marketing, advisory and engagement services.

Website
https://www.medistrava.com/
Industry
Pharmaceutical Manufacturing
Company size
201-500 employees
Headquarters
London, England
Type
Public Company
Specialties
Medical Affairs, Health Economics, Publications, Medical Education, Market Access, and Medical Congresses

Locations

  • Primary

    26 Southampton Buildings

    Holborn Gate, 6th Floor

    London, England WC2A 1AN, GB

    Get directions
  • 300 Vesey St

    10th Floor New York

    Manhattan, New York 10282, US

    Get directions

Employees at MEDiSTRAVA, an Inizio Company

Updates

  • At MEDiSTRAVA we are delighted to have supported Medical Affairs Professional Society (MAPS) with the development of several Standards & Guidance documents. The first of these focuses on advancing excellence in Medical Operations, and addresses the following: · What is Medical Operations and why is it important? · What are the specific responsibilities of Medical Operations across key Medical Affairs workstreams? · How should Medical Operations be designed to optimize its value and perform at its best? · How will Medical Operations need to change in the context of the wider evolution of Medical Affairs? · What additional tools and resources are available to support those working in Medical Operations?

    🌟 New Resource Alert! 🌟 MAPS is excited to announce the release of the “Advancing Excellence in Medical Operations Standards & Guidance” document. This essential resource is designed to empower Medical Affairs professionals by providing practical frameworks and strategies to: ✅ Streamline Medical Operations to improve efficiency and collaboration. ✅ Align operational processes with organizational priorities and business goals. ✅ Foster innovation and support cross-functional communication to drive impactful outcomes. 💡 Key Highlights Include: 1️⃣ Best practices for optimizing workflows and internal collaboration. 2️⃣ Tools to enhance compliance, knowledge sharing, and strategic alignment. 3️⃣ Insights into leveraging Medical Operations to maximize resource utilization and support evidence-based decision-making. 📥 Download the full document now: https://lnkd.in/gZz2GEVE Join us at the MAPS Americas Meeting (March 23–26) for deeper insights into applying this resource to transform your Medical Operations. Dedicated sessions will explore its practical applications and alignment with the Foundations in Medical Affairs course launching at the event. MAPS would like to thank the contributors to the Advancing Excellence in Medical Operations Standards & Guidance document: Brian B., Daiichi Sankyo Kat Long, Mural Oncology Melissa Toler, Harmony Biosciences Rachel Hatfield, Managing Partner, MEDiSTRAVA Consulting Together, we’re shaping the future of Medical Affairs. #MedicalAffairs #MAPSGlobal #JoinTheMovement

    • No alternative text description for this image
  • At MEDiSTRAVA we are delighted to have supported Medical Affairs Professional Society (MAPS) with the development of several Standards & Guidance documents. The Strategic Integrated Evidence Generation Planning: Company and Non-Company Sponsored Research Standards & Guidance addresses the following: · Why is strategic evidence generation planning important? · How can an adaptive strategic evidence generation plan be developed? · How can we ensure our evidence is meaningful for our stakeholders? · How should evidence gaps be prioritized? · How can we successfully implement investigator-initiated studies? · How can the value of the evidence be measured?

    🌟 Explore the latest Standards & Guidance 🌟 The Medical Affairs Professional Society (MAPS) is thrilled to announce the release of the “Strategic Integrated Evidence Generation Planning: Company and Non-Company Sponsored Research” Standards & Guidance. This comprehensive resource provides actionable frameworks and insights for Medical Affairs professionals to: ✅ Discover why strategic Evidence generation planning is important ✅ How adaptive strategic evidence generation plan be developed ✅ How to ensure the evidence is meaningful for stakeholders ✅ From outputs to impact: How can the value of the evidence be measured 📥 Download the full document now: https://lnkd.in/g398Svu2 Join us at the MAPS Americas Meeting (March 23–26) for deeper insights into leveraging this resource and aligning your strategy with cutting-edge Medical Affairs practices. The Medical Affairs Professional Society (MAPS) would like to thank the following contributors to the Value and Impact Guidance Document: Eric Maiese, Senior Director & Head US Health Economics & Outcomes Research, Ipsen Gary Male, Communications Director, Oxford Pharmagenesis Rahul Mandlik, PhD, CCRP®, General Manager Medical Affairs, Shalina Healthcare Daniel Bin Ng, Senior Director, Head of HEOR International Markets and Greater China, Astellas Pharma Global Development Krupa O., Client Services Director, MEDiSTRAVA Phil Wakefield, Chief Advisory Services Officer, Inizio Medical #MAPSNOLA25 #MAPSEvents #MedicalAffairs #JointheMovement

    • No alternative text description for this image
  • At MEDiSTRAVA we are delighted to have supported Medical Affairs Professional Society (MAPS) with the development of several Standards & Guidance documents. The External Scientific Engagement (Field Medical) Standards & Guidance addresses the following: ·       What is the purpose of Field Medical? ·       How can Field Medical Teams be structured? ·       Who are the stakeholders for Field Medical, how should they be engaged? ·       What is the role of insights generation within Field Medical? ·       What skills and capabilities are required success? ·       How can we measure the impact of Field Medical? https://lnkd.in/dBnHfMMG.

    🌟 Discover the latest Standards & Guidance 🌟 The Medical Affairs Professional Society (MAPS) is thrilled to announce the release of the “External Scientific Engagement (Field Medical)” Standards & Guidance. This comprehensive resource provides actionable frameworks and insights for Medical Affairs professionals to: ✅ Provides a structured framework to help Medical Affairs, including Field Medical teams, align strategy with patient impact. ✅ Offers guidance, practical tools, and recommendations to support Field Medical in planning, executing, and evaluating the value and impact of their scientific engagements ✅ Helps Field Medical professionals enhance the effectiveness of their interactions with HCPs ✅ Ensures that medical strategies translate into meaningful outcomes for patients 📥 Download the full document now: https://lnkd.in/gsatm97j Join us at the MAPS Americas Meeting (March 23–26) for deeper insights into leveraging this resource and aligning your strategy with cutting-edge Medical Affairs practices. The Medical Affairs Professional Society (MAPS) would like to thank the following contributors to the Value and Impact Guidance Document: Richard Swank, Ph.D., Founder and Principal, Scientific Engagement LLC Dr. Mussa Arvani, MD, MBA, Medical Group Lead, Roche Pharma Dr. Ekkehard Lange Lange, Regional Medical Director & MSL Lead DM Emma Rankine, PhD MBioSci, Expert in Medical Excellence Mark Rees-Saunders, International Medical Affairs Lead, MSL & Expansion Markets, Exact Sciences Lorna Fergusson, Global Field Medical Excellence Lead, Amgen, Europe GmbH Kelly Lo,  Field Medical Excellence Lead, Amgen, Global and JAPAC  Tom Carey, Principal Consultant, MEDiSTRAVA Consulting #MAPSNOLA25 #MAPSEvents #MedicalAffairs #JointheMovement

    • No alternative text description for this image
  • From improving trial design to enhancing patient engagement, AI is revolutionizing the research landscape. But with innovation comes responsibility—data integrity, diversity, and ethical considerations remain crucial. This article is by Blair Sirockman, dives deep into the evolving role of AI in clinical trials. So, how do we balance AI-driven advancements with the need for rigorous oversight? 🤔 🔗 Read more: https://lnkd.in/eJPWUYwS. #AI #ClinicalTrials #Innovation #HealthcareTech

    • No alternative text description for this image
  • We are pleased to share that Sylvie Berrebi and Sandi Greenwood, from MEDiSTRAVA’s Strategic Communications team will be attending the SACHS 18th Annual European Life Science CEO Forum in Zurich, Switzerland on February 26-27.   Feel free to reach out if you’d like to learn about how we can help to shape and amplify your corporate, scientific, and medical narratives.   Take a look at our capabilities: https://lnkd.in/egUZHrrd

    • No alternative text description for this image
  • It is well known that patients are crucial partners for the pharmaceutical and biotech industry. However, there is still room for improvement when it comes to patient collaboration with the pharmaceutical industry. ❓ Are patient perspectives always sought, and consistently acted on? ❓ Are you asking the right people the right questions? Are you asking them at the right time? ❓ Have you been able to measure the impact of your patient engagement work so far? At MEDISTRAVA, we can help you with all things related to patient engagement. Please visit our website for more information. #PatientEngagement #PatientInsights #PatientCentricity #PatientPartnership

  • Today, we’re celebrating the women driving innovation and shaping the future of healthcare. The MEDiSTRAVA Strategic Communications team is privileged to work alongside some of the brightest minds in the life sciences sector who inspire and innovate every day.   Despite their significant impact, women remain underrepresented and often face unique challenges, particularly in STEM fields. The International Day of Women and Girls in Science celebrates their work and calls for action to break barriers preventing equal participation.   To all the women and girls in science: your passion, dedication, and innovation inspire us all! 💡   #WomenInScience #WomenInSTEM #WomenAndGirlsInScience

    • No alternative text description for this image
  • Today, on World Cancer Day, we recognize the incredible innovation in oncology and the biotech pioneers driving meaningful change for patients.   The MEDiSTRAVA Strategic Communications team are privileged to work with groundbreaking biotech companies developing next-generation therapies—from antibody-drug conjugates (ADCs) to novel cancer immunotherapies and targeted treatments.   Their commitment to advancing science continues to shape the future of cancer care.   #WorldCancerDay #OncologyInnovation #Biotech #CancerResearch

    • No alternative text description for this image
  • Congratulations to our client, Angelini Ventures, on co-leading a €35 million Series B financing raise for Nobi, an AgeTech company with a mission to empower people to age with dignity, safety and happiness. Angelini Ventures selected Nobi as part of its investment strategy to support and advance the most promising healthcare technology companies, from wearable devices to AI-enabled products and solutions, that are transforming industry standards. Congratulations to the Angelini Ventures team on the new portfolio addition! #VentureCapital #Innovation #HealthTech #StrategicCommunications

    View organization page for Angelini Ventures

    8,518 followers

    Proud to announce our strategic investment in Nobi Smart Lamps, a groundbreaking AgeTech company revolutionizing senior care through AI-enabled fall management technology. Nobi's innovative AI-powered smart lights are pioneering a new era in elderly care through intelligent fall detection and prevention. Reducing falls by 51% and emergency response times to just 4 minutes, Nobi transforms safety for elderly populations. Together with our co-lead investor Nexus NeuroTech Ventures, and alongside 15th Rock, EQT Health Economics, EQT Dementia Fund (EQT Group), and PMV, we're supporting Nobi's global expansion and continued platform enhancement. "Nobi delivers meaningful, clinically validated improvements to daily care operations, supporting both residents and caregivers. We see potential beyond fall management, extending to broader health monitoring and care management." - says Tanja Dowe, Managing Director at Angelini Ventures "This funding milestone proves the urgent need for AgeTech solutions that combine cutting-edge technology with award-winning design." comments Roeland Pelgrims, CEO of Nobi. Read more here https://lnkd.in/d3kcE5Ac Transforming senior care, one smart light at a time. 🌟👵🏼🩺 #AgeTech #HealthInnovation #SeniorCare

    • This is a blue background card with text in white announcing the investment as co-lead that Angelini Ventures made in Nobi's AI smart light technology.

On the bottom of the card we can find in white Angelini Ventures logo on the left, Nobi's logo on the right

Affiliated pages

Similar pages

Browse jobs